Evidence map›Paper›PMID 40766915›Full record

ArticleFrontiers in pediatrics2025

Clinical presentation and outcomes of diabetic ketoacidosis in pediatric and adolescent patients at a tertiary hospital in Jordan.

Hanan Al Thiabat, Sara Elbanna, Mohammad Quadier, Mohmmad Dayyeh, Bashar Abunnadi, Hadeel Obeidat, Ala'a Abu Shakhdam, Hala Elfarraj, Miral A Almomani, Faisal Abu-Ekteish

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hanan Al ThiabatDepartment of Pediatrics and Neonatology, Faculty of Medicine, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, Jordan.
Sara ElbannaFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Mohammad QuadierFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Mohmmad DayyehFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Bashar AbunnadiFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Hadeel ObeidatDepartment of Pediatrics and Neonatology, Faculty of Medicine, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, Jordan.
Ala'a Abu ShakhdamDepartment of Pediatrics and Neonatology, Faculty of Medicine, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, Jordan.
Hala ElfarrajDepartment of Pediatrics and Neonatology, Faculty of Medicine, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, Jordan.
Miral A AlmomaniDepartment of Pediatrics and Neonatology, Faculty of Medicine, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, Jordan.
Faisal Abu-EkteishDepartment of Pediatrics and Neonatology, Faculty of Medicine, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Diabetic ketoacidosis (DKA) remains a serious and potentially life-threatening complication of diabetes in children and adolescents, particularly in resource-limited settings, with overall mortality of 3.4%-13.4% in developing countries. Understanding the clinical presentation, treatment outcomes, and complication rates is essential to improving care and reducing morbidity. Methods: A retrospective analysis was conducted on pediatric patients aged 2-16 years admitted with DKA to King Abdulla University Hospital (KAUH) between 2017 and 2023. Data were collected on age, diagnosis status, DKA severity, and clinical outcomes. Results: DKA was most common between 6 and 12 years old (67.8%) with mean age of 9 (IQR = 5). More than two thirds of children were newly diagnosed upon admission (72.4%) while the remainder were known cases of T1DM, 41.1% of patients had severe DKA while 35.7% had moderate DKA. No mortality was reported during the study period. Conclusion: DKA remains a frequent presentation among newly diagnosed pediatric diabetes cases in this setting, with a high proportion of moderate to severe presentations. Despite the severity, no deaths were reported, highlighting the effectiveness of management protocols at KAUH. Continued efforts are needed to improve early diagnosis and reduce complication rates.

Indexed as

cerebral edemaclinical presentationdiabetic ketoacidosisoutcometype 1 diabetes mellitus

Identifiers

PMID40766915
PMCPMC12321755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.